Bioregulator – Start
The Bioregulator Start stack gathers three classic Khavinson peptide bioregulators — Thymalin (immune), Pinealon (pineal/CNS) and Vesugen (vascular) — into one curated kit for foundational research across multiple physiological systems.
Each bioregulator is supplied at research-grade purity for laboratory use. For research purposes only; not for human consumption.
Prețul inițial a fost: 166,00 €.141,00 €Prețul curent este: 141,00 €.
Un kit fundamental de bioregulatori cu Thymalin, Pinealon și Vesugen pentru cercetarea peptidelor multisistemice.
Temporar indisponibil. Lasă datele tale și te anunțăm imediat ce revine.
Bioregulator - Start - Foundational Bioregulator Research Stack
Thymalin
Pinealon
Vesugen
Pinealon
Thymalin
Vesugen
Thymalin
Pinealon
Description
Mechanism of Action
This research stack explores the synergistic potential of peptides targeting key physiological systems. Thymalin investigates immune system modulation, while Pinealon focuses on neuroprotective mechanisms and cognitive function. Vesugen research examines its role in supporting vascular integrity, collectively offering a broad perspective on systemic bioregulation.
Benefits
- Immune System Research – Investigating Thymalin’s role in immune cell function.
- Cognitive Function Studies – Exploring Pinealon’s impact on brain health.
- Vascular Health Exploration – Examining Vesugen’s influence on vessel integrity.
- Neuroprotective Mechanisms – Researching Pinealon’s potential in neuronal support.
- Cellular Regulation Inquiry – Studying Thymalin’s involvement in cellular processes.
Research Data
Thymalin
| Study / Model | Reported effect |
|---|---|
| Aged murine models | ↑ thymic cellularity, ↑ CD4+/CD8+ ratio, restored T-cell output |
| Immunocompromised rodent studies | ↑ IL-2 and interferon-gamma expression, improved lymphocyte proliferation |
| Elderly human observational cohorts | Reduced incidence of respiratory infections and improved immune markers |
| Radiation-exposure animal models | Accelerated hematopoietic recovery and lymphocyte regeneration |
| Chronic inflammation models | ↓ pro-inflammatory cytokines (TNF-α, IL-6), normalized immune balance |
| In vitro thymocyte cultures | Enhanced T-cell maturation and differentiation signaling |
| Geriatric clinical observations | Improved telomerase activity and extended cellular longevity markers |
Pinealon
| Study / Model | Reported effect |
|---|---|
| Aged rat cognitive performance | ↑ memory retention and learning capacity in Morris water maze tasks |
| Cultured cortical neurons (in vitro) | ↓ oxidative stress markers; ↑ neuronal survival under hypoxic conditions |
| Accelerated aging mouse model (SAMP1) | Extended lifespan and preserved cognitive function compared to controls |
| Human fibroblast culture | ↑ telomerase activity and ↑ telomere length over multiple passages |
| Rotenone-induced neurotoxicity model | Reduced apoptosis and preserved mitochondrial integrity in dopaminergic neurons |
| Elderly cognitive decline observational study | Improved attention, memory recall, and psycho-emotional state markers |
| Ischemia-reperfusion brain injury (rat) | ↓ infarct volume; ↑ neuroprotective gene expression including Bcl-2 |
| Sleep-deprivation behavioral model | Normalized circadian markers and reduced stress-induced cognitive deficits |
Vesugen
| Study / Model | Reported effect |
|---|---|
| Aged rat vascular tissue | ↑ endothelial regeneration markers; improved capillary density |
| Human umbilical vein endothelial cell (HUVEC) culture | ↑ proliferation rate and ↓ senescence-associated markers |
| Atherosclerosis animal model | ↓ plaque progression; improved vascular wall integrity |
| Elderly cohort observational study | Improved microcirculation and reduced markers of vascular aging |
| In vitro telomere assay | Telomerase activity preservation in endothelial lineages |
| Hypertensive rat model | ↓ systolic pressure; ↑ nitric oxide bioavailability |
| Diabetic vascular complication model | Reduced endothelial dysfunction and oxidative stress markers |
Stack Suggestions
This research bundle suits researchers exploring foundational systemic bioregulation. It offers a starting point for examining immune, neurological, and vascular pathways, ideal for initial studies into peptide-mediated modulation.
Pen Dosage Chart
Thymalin
| Thymalin Pen 20 mg | |
| Volume | 2 mL |
| mg/mL | 10 mg/mL |
| Click-to-Dose | 1 click = 0.1 mg |
| Example(s) | 10 clicks = 1 mg |
Pinealon
| Pinealon Pen 20 mg | |
| Volume | 2 mL |
| mg/mL | 10 mg/mL |
| Click-to-Dose | 1 click = 0.1 mg |
| Example(s) | 10 clicks = 1 mg |
Vesugen
| Vesugen Pen 20 mg | |
| Volume | 2 mL |
| mg/mL | 10 mg/mL |
| Click-to-Dose | 1 click = 0.1 mg |
| Example(s) | 10 clicks = 1 mg |
Dosage & Protocols Variations
Thymalin
Standard Research Protocol
- Dose: 5 – 10 mg
- Duration: 5 – 10 days
- Frequency: Daily intramuscular administration
- Cycle Interval: 4 – 6 months before repeating
- Goal / Description: Baseline immunomodulatory protocol used in aging and immune restoration models.
Therapeutic Research Protocol
- Dose: 10 – 20 mg
- Duration: 10 – 14 days
- Frequency: Daily
- Cycle Interval: 3 – 6 months off before repeating
- Goal / Description: Higher-dose protocol applied in immunocompromised and chronic inflammation models.
Biohacker Protocol (experimental)
- Dose: 2 – 5 mg
- Duration: 10 – 20 days
- Frequency: Every other day
- Cycle Interval: 2 – 3 times per year
- Goal / Description: Low-dose longevity-oriented schedule explored in epigenetic and thymic regeneration research.
Pinealon
Standard Research Protocol
- Dose: 1 – 3 mg
- Duration: 2 – 4 weeks
- Frequency: Daily
- Cycle Interval: 4 – 8 weeks off before repeating
- Goal / Description: Baseline protocol for neuroprotection and cognitive support models.
Therapeutic Research Protocol
- Dose: 3 – 5 mg
- Duration: 3 – 4 weeks
- Frequency: Daily
- Cycle Interval: 8 – 12 weeks off before repeating
- Goal / Description: Higher-dose regimen used in studies targeting age-related cognitive decline and oxidative stress.
Biohacker Protocol (experimental)
- Dose: 0.5 – 1 mg
- Duration: 6 – 8 weeks
- Frequency: 5× per week
- Cycle Interval: 4 weeks off before repeating
- Goal / Description: Low-dose continuous exposure for longevity and cellular preservation research.
Vesugen
Standard Research Protocol
- Dose: 100 – 200 mcg
- Duration: 4 – 6 weeks
- Frequency: Daily, sublingual or SubQ
- Cycle Interval: 4 – 8 weeks off before repeating
- Goal / Description: Baseline protocol for vascular function and endothelial integrity studies.
Therapeutic Research Protocol
- Dose: 200 – 400 mcg
- Duration: 6 – 8 weeks
- Frequency: Daily
- Cycle Interval: 8 weeks off before repeating
- Goal / Description: Extended protocol used in models targeting vascular aging and microcirculation.
Biohacker Protocol (experimental)
- Dose: 50 – 100 mcg
- Duration: 8 – 12 weeks
- Frequency: Daily, low-dose sublingual
- Cycle Interval: Continuous with 2-week pauses every 12 weeks
- Goal / Description: Microdose approach explored in longevity-oriented vascular research.
Possible Side Effects
Thymalin
Thymalin is generally well-tolerated in clinical and preclinical studies involving elderly and immunocompromised populations.
Reported side effects are infrequent and mild:
- Transient redness or mild swelling at the injection site.
- Occasional low-grade fever during initial dosing in immunocompromised models.
- Mild fatigue or drowsiness reported in early administration phases.
- Rare allergic-type reactions in sensitive subjects.
No evidence of hepatic, endocrine, or systemic toxicity has been observed in available research data.
Pinealon
Pinealon is generally well-tolerated in animal studies and limited human observational research.
Reported side effects are infrequent and mild:
- Transient mild headache during initial dosing.
- Localized irritation or redness at injection site.
- Occasional drowsiness or altered sleep patterns.
- Mild gastrointestinal discomfort in sensitive subjects.
No evidence of hormonal, hepatic, or neurotoxic adverse effects has been observed in available preclinical data. As a short tripeptide, Pinealon is rapidly metabolized into its constituent amino acids, which contributes to its favorable tolerability profile in experimental models.
Vesugen
Vesugen is generally well-tolerated in preclinical and limited observational studies.
Reported side effects are rare and mild:
- Mild localized irritation at the injection site.
- Transient headache during initial dosing periods.
- Occasional digestive sensitivity in sensitive subjects.
- Slight fatigue reported in early observational use.
No evidence of hormonal, hepatic, or systemic adverse effects has been observed in available research data. As a short tripeptide bioregulator, Vesugen is structurally similar to endogenous peptide fragments, which is associated with its low reported toxicity profile in experimental models.
Product Attributes
Scientific References
Thymalin
- Thymalin: clinical-experimental investigation in elderly and aged patients Observational | Animal
- Khavinson VK. Peptides and ageing Observational | Animal
- Anti-inflammatory and anti-aging effects of thymic peptide bioregulators in COVID-19 elderly patients Observational
- Peptide regulation of cell differentiation and gene expression in aging Animal | In vitro
- Short peptides and telomere length regulator hormone irisin: a novel approach to age-related diseases Observational | In vitro
- Effect of thymalin on the immune system and lifespan of mice Animal
- Peptide bioregulators: a novel direction of preventive gerontology Observational | Animal
- Influence of thymalin on functional activity of immune cells in patients with acute pneumonia Observational
Pinealon
- Short peptides stimulate cell regeneration in skin during aging Animal | In vitro
- Peptide regulation of cell differentiation Animal | In vitro
- Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation during aging Animal | In vitro
- Tripeptides restore the number of neuronal spines under conditions of in vitro modeled Alzheimer’s disease In vitro
- Pinealon enhances resistance of cells of cerebral cortex of rat embryos to oxidative stress Animal | In vitro
- Peptidergic regulation of cell proliferation and renewal during aging Observational | Animal
- Neuroprotective effects of peptide bioregulators in experimental models of neurodegeneration Animal | In vitro
Vesugen
- Vascular wall peptide bioregulator prevents the H2O2-induced damage of endothelial cells Animal | In vitro
- Peptide KED: molecular-genetic aspects of neuroendocrine system regulation in aging In vitro
- Short peptides stimulate cell regeneration suppressed in elderly after stress exposure Animal | In vitro
- Peptidergic regulation of cell differentiation in 3D cell cultures In vitro
- Tripeptide KED induces vasoprotective and antioxidant gene expression in vascular endothelium In vitro
- Short peptides and telomere length regulator hTERT gene expression In vitro
- Geroprotective effects of short peptides in aging vascular research models Observational | Animal
- Molecular aspects of peptide bioregulation in vascular and endothelial tissue Observational | In vitro
Inclus în cutie
Fiecare produs sosește într-o cutie premium PEPTIDE.Power personalizată, proiectată pentru comoditate, igienă și depozitare sigură în frigider. În interior, veți găsi tot ce este necesar pentru protocolul dumneavoastră complet de cercetare:
- 1× Stilou de injecție pre-amestecat de unică folosință
- Alimentat de Tehnologia PSM™ – sistem de stabilizare și amestecare de precizie pentru potență constantă
- 10× Ace ultra-subțiri (33G, 4 mm)
- 10× Tampoane cu alcool pentru pregătire sterilă
- Insert din spumă stabilizatoare internă pentru prevenirea agitării în timpul transportului
- Panou de instrucțiuni imprimat pe interiorul cutiei pentru referință rapidă
- Autocolant sigiliu de securitate care asigură că pachetul nu a fost deschis sau modificat
Depozitare
A se păstra produsul la frigider la 1 – 7°C imediat după livrare. Pentru a menține o stabilitate optimă, țineți stiloul ferit de lumină și nu îl expuneți la schimbări repetate de temperatură.
Odată reconstituite (toate stilourile noastre vin pre-amestecate), compușii de cercetare rămân stabili timp de 6 – 8 săptămâni sub refrigerare adecvată.
Nu congelați după reconstituire. Păstrați întotdeauna cutia închisă astfel încât stiloul, acele și tampoanele cu alcool să rămână curate și protejate.
Pentru cele mai bune rezultate, utilizați produsul în mod constant în intervalul de timp recomandat și urmați întotdeauna protocolul dumneavoastră de cercetare.
Livrare
Expediem cu Livrare în UE în ziua următoare prin DHL Express sau UPS Express.
Toate comenzile sunt pregătite proaspăt în ziua expedierii, plasate în cutii de transport cu lanț de frig EPS și expediate cu elemente de răcire pentru a menține o temperatură stabilă pe tot parcursul călătoriei.
Procesul nostru logistic este conceput astfel încât pachetul să sosească a doua zi, evitând întârzierile vamale în interiorul Uniunii Europene.
Produsele sunt expediate din facilitatea noastră din UE, asigurând fără taxe de import, fără vămuire și întotdeauna livrare rapidă și sigură.
Plată
Din cauza naturii peptidelor de cercetare și a categoriei de risc ridicat atribuită de procesatorii de plăți, companiile de carduri de credit nu susțin comercianții din acest domeniu.
Din acest motiv, acceptăm doar transferuri bancare.
În cadrul Uniunii Europene, transferurile SEPA sunt rapide, cu costuri reduse și de obicei ajung în câteva minute până la câteva ore, făcând procesul de plată simplu și ușor.
Odată ce transferul este primit, comanda dumneavoastră este pregătită imediat și expediată în aceeași zi (în funcție de ora limită).
Această metodă asigură conformitatea, securitatea și continuitatea serviciului pentru toți clienții din UE.
Nu ați găsit răspunsul la întrebarea dvs.?
Vedeți toate întrebările frecventeRELATED PRODUCTS
